Product Variations
Product # | Price | Quantity | |
---|---|---|---|
VD-Ant-0256-0005-5g | $320 | ||
VD-Ant-0256-0020-20g | $1200 |
$320.00 – $1,200.00
White or off-white crystalline powder.
112809-51-5
VD-Ant-0256
C17H11N5
285.31
>=98%
Dichloromethane.
+2°C to +8°C. Protect from light.
CGS-20267
20g, 5g
Product # | Price | Quantity | |
---|---|---|---|
VD-Ant-0256-0005-5g | $320 | ||
VD-Ant-0256-0020-20g | $1200 |
Letrozole (CAS 112809-51-5) is a nonsteroidal aromatase inhibitor structurally related to Fadrozole, that has been introduced for the adjuvant treatment of hormonally-responsive breast cancer. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. Antineoplastic.
1.Ingle JN. Oncology (Huntingt). 15:28-34 (2001).
2.Brodie AM. J Steroid Biochem Mol Biol. 49:281-7 (1994).
Reviews
There are no reviews yet.